Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2020-08-14 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
独立董事对公司关联方资金占用和对外担保情况的专项说明及独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion by independent directors regarding related party fund occupation and external guarantees for the half-year period ending June 30, 2020. It references regulatory notices and stock exchange listing rules, and provides detailed information on financial support and guarantees involving related parties. The document is not a full financial report but a specific audit or compliance-related statement focusing on related party transactions and guarantees. It does not contain comprehensive financial statements or management discussion but is a standalone report on audit and compliance matters related to external guarantees and related party funds. Therefore, it fits best under Audit Report / Information (AR). The document length is short (1262 characters), but it contains substantive content rather than just an announcement or certification, so it is not RPA or RNS. H1 2020
2020-08-14 Chinese
2015年公司债券2020年兑付兑息暨摘牌公告
Delisting Announcement Classification · 95% confidence The document is an official announcement regarding the maturity, interest payment, and delisting (摘牌) of a corporate bond issued by 华邦生命健康股份有限公司. It details the bond's basic information, payment schedule, tax implications, and related institutions. The key terms include '兑付兑息' (redemption and interest payment) and '摘牌公告' (delisting announcement). The document length is 3654 characters, which is relatively short and focused on a specific event rather than a comprehensive financial report. It is not an annual or interim report, audit report, or earnings release. The primary purpose is to announce the bond's redemption and its removal from the exchange. Therefore, the most appropriate classification is a Delisting Announcement (DLST).
2020-08-11 Chinese
关于公司董事减持股份的预披露公告
Director's Dealing Classification · 100% confidence The document is a pre-disclosure announcement regarding a planned reduction of shares held by a company director, Mr. Yu Juntian. It details the number of shares held, the planned reduction amount, the timeframe, and compliance with relevant securities regulations. The document does not contain financial statements, earnings data, or management discussion, nor is it a report or presentation. It is a notification about a director's personal share transactions (share dealing). Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on this topic, confirming the classification.
2020-07-16 Chinese
关于控股子公司山东凯盛新材料股份有限公司首次公开发行股票并在创业板上市获深圳证券交易所受理的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (600 characters) regarding the acceptance by the Shenzhen Stock Exchange of the application for the initial public offering (IPO) and listing of a controlling subsidiary on the Growth Enterprise Market. It is a notification about a capital market event related to stock issuance and listing, not a full financial report or detailed presentation. The document does not contain financial statements or detailed analysis but is an update on financing activity. Therefore, it fits best under Capital/Financing Update (CAP).
2020-07-07 Chinese
关于控股子公司山东凯盛新材料股份有限公司通过山东证监局首次公开发行股票并在创业板上市辅导验收的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (587 characters) regarding a subsidiary's completion of regulatory guidance and acceptance for an initial public offering (IPO) on the Growth Enterprise Market (创业板). It references a regulatory letter from the Shandong Securities Regulatory Bureau and confirms the completion of the guidance acceptance process. There are no financial statements, detailed financial data, or comprehensive reports included. The document serves as a regulatory update or notification about the subsidiary's IPO progress rather than a full report or detailed financial disclosure. It is not an Annual Report, Interim Report, Earnings Release, or any detailed financial or management report. It is also not a proxy, voting result, or remuneration report. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-06-29 Chinese
关于控股股东股份质押及解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Huabang Life Health Co., Ltd. regarding the pledge and release of shares by its controlling shareholder, Tibet Huibang Technology Co., Ltd. It details the number of shares pledged, released, and cumulative pledges, along with related dates and percentages. The content focuses on share pledging activities and financing arrangements by major shareholders, not on financial results, management changes, or legal matters. The document length is 2777 characters, which is relatively short and typical for a share pledge announcement. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share pledges.
2020-06-29 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.